PetVivo raises $5M via Series B Convertible Preferred Stock; initial $600K funded

PetVivo Holdings, Inc.

$5M Series B Convertible Preferred offering at $1.00/share; $600K initial, option for additional $4.4M.
Preferred stock carries 10% annual dividend payable in common stock; shares convertible 1:1 into common.
Company call option after 2 years at $1.15/share; holder may convert during 30-day call period.
Proceeds for commercialization of Spryng™ and PrecisePRP, clinical trials, and working capital.
Filed Certificate of Designation for Series B Preferred with Nevada Secretary of State.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.